164 related articles for article (PubMed ID: 22169281)
1. [Expression of histone demethylase lysine specific demethylase 1 in acute leukemia and its clinical significance].
Lin XM; Zhong WT; Wang CL; Wang SQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1348-52. PubMed ID: 22169281
[TBL] [Abstract][Full Text] [Related]
2. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines.
Murray-Stewart T; Woster PM; Casero RA
Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577
[TBL] [Abstract][Full Text] [Related]
3. CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1.
Lynch JT; Cockerill MJ; Hitchin JR; Wiseman DH; Somervaille TC
Anal Biochem; 2013 Nov; 442(1):104-6. PubMed ID: 23911524
[TBL] [Abstract][Full Text] [Related]
4. [Expression of FANCG gene in acute myeloid leukemia].
Duan XL; Wang QL; Wang JG; Wang CY; Fan H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):7-11. PubMed ID: 23484681
[TBL] [Abstract][Full Text] [Related]
5. Targeting LSD1 for acute myeloid leukemia (AML) treatment.
Zhang S; Liu M; Yao Y; Yu B; Liu H
Pharmacol Res; 2021 Feb; 164():105335. PubMed ID: 33285227
[TBL] [Abstract][Full Text] [Related]
6. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
[TBL] [Abstract][Full Text] [Related]
7. [NT5C2 expression in children with acute leukemia and its clinical significance].
Wang Y; An X; Liu J; Zhang N; Liu Z; Liang S; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):748-53. PubMed ID: 26462774
[TBL] [Abstract][Full Text] [Related]
8. [Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance].
Zhang R; Sun HQ; Li G; Bai FY; Yang Y; Jing Q; Shi YJ; Yang JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):959-63. PubMed ID: 21867623
[TBL] [Abstract][Full Text] [Related]
9. [CD96 expression on bone marrow mononuclear cells in 91 patients with acute leukemia].
Wu Y; Xiao M; Zhu L; Zhou XX; Gong Q; Xin X; Li CR; Zhou JF; Deng JN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):585-8. PubMed ID: 21729528
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia.
Przespolewski A; Wang ES
Expert Opin Investig Drugs; 2016 Jul; 25(7):771-80. PubMed ID: 27077938
[TBL] [Abstract][Full Text] [Related]
11. The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1.
Carmichael CL; Wang J; Nguyen T; Kolawole O; Benyoucef A; De Mazière C; Milne AR; Samuel S; Gillinder K; Hediyeh-Zadeh S; Vo ANQ; Huang Y; Knezevic K; McInnes WRL; Shields BJ; Mitchell H; Ritchie ME; Lammens T; Lintermans B; Van Vlierberghe P; Wong NC; Haigh K; Thoms JAI; Toulmin E; Curtis DJ; Oxley EP; Dickins RA; Beck D; Perkins A; McCormack MP; Davis MJ; Berx G; Zuber J; Pimanda JE; Kile BT; Goossens S; Haigh JJ
Blood; 2020 Aug; 136(8):957-973. PubMed ID: 32369597
[TBL] [Abstract][Full Text] [Related]
12. Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc.
Nagasaka M; Tsuzuki K; Ozeki Y; Tokugawa M; Ohoka N; Inoue Y; Hayashi H
Biol Pharm Bull; 2019; 42(3):481-488. PubMed ID: 30828079
[TBL] [Abstract][Full Text] [Related]
13. [Methylation of Id4 gene promoter in acute leukemia].
Zhao Y; Wang QS; Dou LP; Bo J; Li HH; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1156-60. PubMed ID: 18088456
[TBL] [Abstract][Full Text] [Related]
14. [Expression of FoxO3a in patients with acute myeloid leukemia and its clinical significance].
Zhao JN; Lu QY; Niu XQ; Zhang P; Wang Z; Lin JZ; Zhuang YH; Lu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):847-50. PubMed ID: 23998572
[TBL] [Abstract][Full Text] [Related]
15. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
Braun TP; Coblentz C; Curtiss BM; Coleman DJ; Schonrock Z; Carratt SA; Callahan RL; Maniaci B; Druker BJ; Maxson JE
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13670-13679. PubMed ID: 32471953
[TBL] [Abstract][Full Text] [Related]
17. [PRPS1 Expression in Children with Acute Leukemia and Its Clinical Significance].
Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
[TBL] [Abstract][Full Text] [Related]
18. [Dynamically monitoring minimal residual disease in acute leukemia after complete remission by multiparameter flow cytometry and its relation with prognosis].
Sun NN; Gan SL; Sun H; Zhang QT; Liu YF; Xie XS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):339-42. PubMed ID: 23628028
[TBL] [Abstract][Full Text] [Related]
19. [Expression of cdx2 gene in pediatric patients with leukemia and its clinical significance].
Li YX; Pan KL; Fan F; Qian XH; Yang XL; Deng YL; Liu YD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):130-3. PubMed ID: 21362237
[TBL] [Abstract][Full Text] [Related]
20. Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells.
Liu S; Lu W; Li S; Li S; Liu J; Xing Y; Zhang S; Zhou JZ; Xing H; Xu Y; Rao Q; Deng C; Wang M; Wang J
Oncotarget; 2017 May; 8(19):31901-31914. PubMed ID: 28404874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
